At its Jan meeting, our safety committee the
https://nitter.cz/search?q=%23PRAC
:
✅recommended measures to address a potential risk of neurodevelopmental disorders in children born to men treated with
https://nitter.cz/search?q=%23valproate
✅started a review of
https://nitter.cz/search?q=%23CARTcell
💊
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-january-2024

🐦🔗: https://nitter.cz/EMA_News/status/1745777485797622139#m

[2024-01-12 11:59 UTC]